These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 85192)

  • 41. Insulin administration via a subcutaneous catheter. Effects on absorption.
    Käär ML; Mäenpää J; Knip M
    Diabetes Care; 1993 Oct; 16(10):1412-3. PubMed ID: 8269809
    [No Abstract]   [Full Text] [Related]  

  • 42. Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.
    Pontiroli AE; Alberetto M; Secchi A; Dossi G; Bosi I; Pozza G
    Br Med J (Clin Res Ed); 1982 Jan; 284(6312):303-6. PubMed ID: 6800439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation.
    Endo JO; Röcken C; Lamb S; Harris RM; Bowen AR
    J Am Acad Dermatol; 2010 Dec; 63(6):e113-4. PubMed ID: 21093656
    [No Abstract]   [Full Text] [Related]  

  • 44. Lack of glucagon response to hypoglycemia in diabetic autonomic neuropathy.
    Maher TD; Tanenberg RJ; Greenberg BZ; Hoffman JE; Doe RP; Goetz FC
    Diabetes; 1977 Mar; 26(3):196-200. PubMed ID: 838171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The intravenous, intraperitoneal, and subcutaneous routes of insulin delivery in diabetic man.
    Schade DS; Eaton RP; Friedman N; Spencer W
    Diabetes; 1979 Dec; 28(12):1069-72. PubMed ID: 510804
    [No Abstract]   [Full Text] [Related]  

  • 46. Defective absorption of injected insulin.
    Lancet; 1978 Sep; 2(8092 Pt 1):741. PubMed ID: 80671
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of insulin-resistant form of diabetes mellitus by intravenous droplet infusion of insulin].
    Pliats OM
    Probl Endokrinol (Mosk); 1978; 24(4):14-7. PubMed ID: 567349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Intensive medicine. Acute threatening metabolic disorders in diabetes mellitus].
    Späth G
    Munch Med Wochenschr; 1972 Oct; 114(43):1882-6. PubMed ID: 4629328
    [No Abstract]   [Full Text] [Related]  

  • 49. The physiological rationale for oral insulin administration.
    Arbit E
    Diabetes Technol Ther; 2004 Aug; 6(4):510-7. PubMed ID: 15321008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Insulin application techniques in adult patients with diabetes].
    Pelcl T; Prázný M
    Vnitr Lek; 2016; 62(6):486-90. PubMed ID: 27485848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Adverse effects of insulin].
    Uchigata Y
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():173-7. PubMed ID: 18074534
    [No Abstract]   [Full Text] [Related]  

  • 52. Technosphere insulin: inhaled prandial insulin.
    Setji TL; Hong BD; Feinglos MN
    Expert Opin Biol Ther; 2016; 16(1):111-7. PubMed ID: 26567896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical control of diabetes by the artificial pancreas.
    Albisser AM; Leibel BS; Ewart TG; Davidovac Z; Botz CK; Zingg W; Schipper H; Gander R
    Diabetes; 1974 May; 23(5):397-404. PubMed ID: 4598090
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.
    Gerich JE; Lorenzi M; Schneider V; Karam JH; Rivier J; Guillemin R; Forsham PH
    N Engl J Med; 1974 Sep; 291(11):544-7. PubMed ID: 4604408
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of plateau insulin levels achieved by intravenous or subcutaneous insulin infusion: evidence for low rates of subcutaneous degradation.
    Kraegen EW; Chisholm DJ; Hewett MJ
    Diabetes Care; 1983; 6(2):118-21. PubMed ID: 6343015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New methods of treatment for diabetes mellitus.
    Rizza RA; Service FJ; Gerich JE
    Compr Ther; 1982 Apr; 8(4):62-70. PubMed ID: 7044664
    [No Abstract]   [Full Text] [Related]  

  • 57. Continuous infusion of subcutaneous compared to intravenous insulin for tight glycaemic control in medical intensive care unit patients.
    Bodur HA; Saygili F; Saygili S; Doganay LH; Yesil S
    Anaesth Intensive Care; 2008 Jul; 36(4):520-7. PubMed ID: 18714620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steroid hyperglycemia.
    Khurana A; Vinayek N
    J Hosp Med; 2007 Jul; 2(4):285; author reply 285-6. PubMed ID: 17705218
    [No Abstract]   [Full Text] [Related]  

  • 59. Intraindividual comparison of pharmacokinetics of insulin after intravenous, portal, subcutaneous and peritoneal administration.
    Fritze K; Fischer U; Freyse EJ; Besch W
    Exp Clin Endocrinol; 1988 Mar; 92(3):297-306. PubMed ID: 3075553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.